The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

A Hundred Experts Urge Strengthening Early Diagnosis of Pulmonary Hypertension in Latin America ...

Halo Biosciences ("Halo"), a clinical-stage biotechnology company developing extracellular matrix-targeted therapies, today ...

Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery ...

The spring meeting of the Irish Society for Rheumatology brought together experts from across Ireland and the UK to highlight ...

This learning unit on venous thromboembolism prevention will support nurses in helping hospitalised patients minimise their ...

Researchers warn of increased cannabis use among older US adults, as experts link it to health risks and complications in chronic disease management.

Johnson & Johnson announced today initial Phase 1 results of JNJ-79635322 (JNJ-5322), a novel investigational trispecific antibody (TsAb) in patients with relapsed or refractory multiple myeloma.

Yutrepia is an inhaled dry powder formulation of treprostinil approved in the U.S. to improve exercise capacity in PAH and PH ...

BST Global, the leading provider of AI-powered project intelligencetm solutions for the AEC industry, hosted its second annual AI Summit, May 6?8, 2025, in Palm Beach, FL. The premier event brought ...

Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.